ORPHA:178469
Autosomal dominant non-syndromic intellectual disability
- Type
- Etiological subtype
- Group
- Subtype of disorder
- Inheritance
- Autosomal dominant
- Age of onset
- Childhood, Infancy
- Status
- active
This disease is described under Rare non-syndromic intellectual disability
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Autosomal dominant non-syndromic intellectual disability | |
| fr | Déficience intellectuelle non syndromique autosomique dominante | |
| de | Intelligenzminderung, nicht-syndromale, autosomal-dominante | |
| es | Discapacidad intelectual no sindrómica autosómica dominante | |
| it | Disabilità intellettiva non sindromica autosomica dominante | |
| nl | Autosomaal dominante niet-syndromale intellectuele achterstand | |
| pt | Perturbação do desenvolvimento intelectual não-sindromática autossómica dominante | |
| pl | Autosomalna dominująca niesyndromiczna niepełnosprawność intelektualna | |
| cs | Autozomálně dominantní nesyndromická mentální retardace | |
| uk | Аутосомно-домінантна несиндромальна інтелектуальна недостатність | |
| zh | 常染色体显性遗传非综合征性智力障碍 | |
| tr | Otozomal dominant, non-sendromik zihinsel yetersizlik |
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 156200 | BTNT | validated | |
| OMIM | 612082 | BTNT | validated | |
| OMIM | 612580 | BTNT | validated | |
| OMIM | 612581 | BTNT | validated | |
| OMIM | 614113 | BTNT | validated | |
| OMIM | 614254 | BTNT | validated | |
| OMIM | 614256 | BTNT | validated | |
| OMIM | 614257 | BTNT | validated | |
| OMIM | 614563 | BTNT | not yet validated | |
| OMIM | 616579 | BTNT | validated | |
| OMIM | 616977 | BTNT | validated | |
| OMIM | 617600 | BTNT | validated | |
| OMIM | 617601 | BTNT | validated | |
| OMIM | 617796 | BTNT | validated | |
| OMIM | 617798 | BTNT | validated | |
| OMIM | 617799 | BTNT | validated | |
| OMIM | 617854 | BTNT | validated | |
| OMIM | 618095 | BTNT | validated | |
| OMIM | 618106 | BTNT | validated | |
| OMIM | 618330 | BTNT | validated | |
| OMIM | 618709 | BTNT | validated | |
| OMIM | 619188 | BTNT | validated | |
| OMIM | 619575 | BTNT | validated | |
| OMIM | 619927 | BTNT | validated | |
| OMIM | 620114 | BTNT | validated | |
| OMIM | 620224 | BTNT | validated | |
| OMIM | 620502 | BTNT | validated | |
| ICD-10 | F70 | BTNT | attributed | validated |
| ICD-10 | F71 | BTNT | attributed | validated |
| ICD-10 | F72 | BTNT | attributed | validated |
| ICD-10 | F73 | BTNT | attributed | validated |
| ICD-11 | LD90.Y | NTBT | attributed | validated |
| MONDO | 0015802 | E | validated | |
| UMLS | C5680502 | E | validated | |
| GARD | 12107 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:101685Rare non-syndromic intellectual disability
rare genetic diseases; rare neurological diseases
No children.
4
Genes
42 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| KDM5B | Candidate gene tested in | Not yet assessed | HGNC:18039 | ENSG00000117139 | 605393 | 1q32.1 | lysine demethylase 5B | 24307393[PMID] |
| BRSK2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:11405 | ENSG00000174672 | 609236 | 11p15.5 | BR serine/threonine kinase 2 | 30879638[PMID] |
| CIC | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:14214 | ENSG00000079432 | 612082 | 19q13.2 | capicua transcriptional repressor | 28288114[PMID] |
| CSNK2B | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:2460 | ENSG00000204435 | 115441 | 6p21.33 | casein kinase 2 beta | 28585349[PMID] |
| HIVEP2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:4921 | ENSG00000010818 | 143054 | 6q24.2 | HIVEP zinc finger 2 | 26153216[PMID]_27003583[PMID] |
| TAOK1 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:29259 | ENSG00000160551 | 610266 | 17q11.2 | TAO kinase 1 | 31230721[PMID] |
| ARF3 | Disease-causing germline mutation(s) in | Assessed | HGNC:654 | ENSG00000134287 | 103190 | 12q13.12 | ARF GTPase 3 | 34346499[PMID] |
| ASH1L | Disease-causing germline mutation(s) in | Assessed | HGNC:19088 | ENSG00000116539 | 607999 | 1q22 | ASH1 like histone lysine methyltransferase | 23033978[PMID]_28394464[PMID] |
| CACNA1I | Disease-causing germline mutation(s) in | Assessed | HGNC:1396 | ENSG00000100346 | 608230 | 22q13.1 | calcium voltage-gated channel subunit alpha1 I | 33704440[PMID] |
| CACNG2 | Disease-causing germline mutation(s) in | Assessed | HGNC:1406 | ENSG00000166862 | 602911 | 22q12.3 | calcium voltage-gated channel auxiliary subunit gamma 2 | 21376300[PMID] |
| CAMK2A | Disease-causing germline mutation(s) in | Assessed | HGNC:1460 | ENSG00000070808 | 114078 | 5q32 | calcium/calmodulin dependent protein kinase II alpha | 29100089[PMID] |
| CAMK2B | Disease-causing germline mutation(s) in | Assessed | HGNC:1461 | ENSG00000058404 | 607707 | 7p13 | calcium/calmodulin dependent protein kinase II beta | 29100089[PMID] |
| CDH15 | Disease-causing germline mutation(s) in | Assessed | HGNC:1754 | ENSG00000129910 | 114019 | 16q24.3 | cadherin 15 | 19012874[PMID] |
| CLTC | Disease-causing germline mutation(s) in | Assessed | HGNC:2092 | ENSG00000141367 | 118955 | 17q23.1 | clathrin heavy chain | 29100083[PMID] |
| CTNND2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2516 | ENSG00000169862 | 604275 | 5p15.2 | catenin delta 2 | 33718894[PMID] |
| CUX1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2557 | ENSG00000257923 | 116896 | 7q22.1 | cut like homeobox 1 | 30014507[PMID] |
| DLL1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2908 | ENSG00000198719 | 606582 | 6q27 | delta like canonical Notch ligand 1 | 31353024[PMID] |
| DOCK8 | Disease-causing germline mutation(s) in | Assessed | HGNC:19191 | ENSG00000107099 | 611432 | 9p24.3 | dedicator of cytokinesis 8 | 18060736[PMID] |
| DPYSL2 | Disease-causing germline mutation(s) in | Assessed | HGNC:3014 | ENSG00000092964 | 602463 | 8p21.2 | dihydropyrimidinase like 2 | 35861646[PMID] |
| DYNC1H1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2961 | ENSG00000197102 | 600112 | 14q32.31 | dynein cytoplasmic 1 heavy chain 1 | 22368300[PMID] |
| EPB41L1 | Disease-causing germline mutation(s) in | Assessed | HGNC:3378 | ENSG00000088367 | 602879 | 20q11.23 | erythrocyte membrane protein band 4.1 like 1 | 21376300[PMID] |
| ERBB4 | Disease-causing germline mutation(s) in | Assessed | HGNC:3432 | ENSG00000178568 | 600543 | 2q34 | erb-b2 receptor tyrosine kinase 4 | 33603162[PMID] |
| GABBR1 | Disease-causing germline mutation(s) in | Assessed | HGNC:4070 | ENSG00000204681 | 603540 | 6p22.1 | gamma-aminobutyric acid type B receptor subunit 1 | 36103875[PMID] |
| GRIA1 | Disease-causing germline mutation(s) in | Assessed | HGNC:4571 | ENSG00000155511 | 138248 | 5q33.2 | glutamate ionotropic receptor AMPA type subunit 1 | 28628100[PMID] |
| GRIN1 | Disease-causing germline mutation(s) in | Assessed | HGNC:4584 | ENSG00000176884 | 138249 | 9q34.3 | glutamate ionotropic receptor NMDA type subunit 1 | 21376300[PMID] |
| ITSN1 | Disease-causing germline mutation(s) in | Assessed | HGNC:6183 | ENSG00000205726 | 602442 | 21q22.11 | intersectin 1 | 34707297[PMID] |
| KCNQ2 | Disease-causing germline mutation(s) in | Assessed | HGNC:6296 | ENSG00000075043 | 602235 | 20q13.33 | potassium voltage-gated channel subfamily Q member 2 | 33754465[PMID] |
| KCNQ5 | Disease-causing germline mutation(s) in | Assessed | HGNC:6299 | ENSG00000185760 | 607357 | 6q13 | potassium voltage-gated channel subfamily Q member 5 | 28669405[PMID] |
| KIRREL3 | Disease-causing germline mutation(s) in | Assessed | HGNC:23204 | ENSG00000149571 | 607761 | 11q24.2 | kirre like nephrin family adhesion molecule 3 | 19012874[PMID] |
| MBD5 | Disease-causing germline mutation(s) in | Assessed | HGNC:20444 | ENSG00000204406 | 611472 | 2q23.1 | methyl-CpG binding domain protein 5 | 23422940[PMID] |
| NBEA | Disease-causing germline mutation(s) in | Assessed | HGNC:7648 | ENSG00000172915 | 604889 | 13q13.3 | neurobeachin | 30269351[PMID] |
| PRICKLE2 | Disease-causing germline mutation(s) in | Assessed | HGNC:20340 | ENSG00000163637 | 608501 | 3p14.1 | prickle planar cell polarity protein 2 | 34092786[PMID] |
| RAB11A | Disease-causing germline mutation(s) in | Assessed | HGNC:9760 | ENSG00000103769 | 605570 | 15q22.31 | RAB11A, member RAS oncogene family | 29100083[PMID] |
| SCN2A | Disease-causing germline mutation(s) in | Assessed | HGNC:10588 | ENSG00000136531 | 182390 | 2q24.3 | sodium voltage-gated channel alpha subunit 2 | 31904126[PMID]_38651838[PMID] |
| SCN8A | Disease-causing germline mutation(s) in | Assessed | HGNC:10596 | ENSG00000196876 | 600702 | 12q13.13 | sodium voltage-gated channel alpha subunit 8 | 16236810[PMID] |
| SEMA6B | Disease-causing germline mutation(s) in | Assessed | HGNC:10739 | ENSG00000167680 | 608873 | 19p13.3 | semaphorin 6B | 35604360[PMID] |
| SET | Disease-causing germline mutation(s) in | Assessed | HGNC:10760 | ENSG00000119335 | 600960 | 9q34.11 | SET nuclear proto-oncogene | 29688601[PMID] |
| SETD1B | Disease-causing germline mutation(s) in | Assessed | HGNC:29187 | ENSG00000139718 | 611055 | 12q24.31 | SET domain containing 1B, histone lysine methyltransferase | 32546566[PMID] |
| SLC6A1 | Disease-causing germline mutation(s) in | Assessed | HGNC:11042 | ENSG00000157103 | 137165 | 3p25.3 | solute carrier family 6 member 1 | 34006619[PMID] |
| TCF4 | Disease-causing germline mutation(s) in | Assessed | HGNC:11634 | ENSG00000196628 | 602272 | 18q21.2 | transcription factor 4 | 22670824[PMID] |
| TRPM3 | Disease-causing germline mutation(s) in | Assessed | HGNC:17992 | ENSG00000083067 | 608961 | 9q21.12-q21.13 | transient receptor potential cation channel subfamily M member 3 | 31278393[PMID] |
| YWHAZ | Disease-causing germline mutation(s) in | Assessed | HGNC:12855 | ENSG00000164924 | 601288 | 8q22.3 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 36001342[PMID] |
5
Prevalence and incidence
0 recordsNo prevalence record in this release.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/178469
- This record as JSON: /data/d/178469.json